Pharmacotherapy in Psychiatry and Neurology
November 6, 2026
Kirolos Eskandar, Kerolos Shahat
To critically synthesize randomized controlled evidence on the efficacy, relapse prevention, durability, and safety of psilocybin-assisted therapy in adults with alcohol use disorder (AUD), distinguishing alcohol-consumption reduction, abstinence, and relapse outcomes.PubMed, Scopus, Web of Science, and the Cochrane Library were searched without date or language restrictions.Three randomized...
Pharmacotherapy in Psychiatry and Neurology
2023
Monika Nowak, Julia Górczyńska, Michał Gebuza
AMA Nowak M, Górczyńska J, Gebuza M. MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):131-142. doi:10.5114/fpn.2023.133519. APA Nowak, M., Górczyńska, J., & Gebuza, M. (2023). MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review....
Pharmacotherapy in Psychiatry and Neurology
2023
Jakub Schimmelpfennig, Kamila Jankowiak-Siuda
AMA Schimmelpfennig J, Jankowiak-Siuda K. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(2):115-130. doi:10.5114/fpn.2023.131979. APA Schimmelpfennig, J., & Jankowiak-Siuda, K. (2023). Therapeutic potential of N,N-dimethyltryptamine in...
Pharmacotherapy in Psychiatry and Neurology
2020
Kamil Kozera, Lena Cichoń, Krzysztof M. Wilczyński et al.
MDMA (3,4-methylenedioxymethamphetamine) is a psychoactive substance classified as a hallucinogen. MDMA acts in the brain through a variety of neurochemical mechanisms, reducing anxiety, giving a sense of oneness with other people, expanding empathy, sharpening the senses and intensifying the experience of emotions. Therefore, the use of the MDMA assisted psychotherapy is being considered in...